These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3787624)

  • 1. Tissue distribution of cadmium and nephropathy after administration of cadmium in several chemical forms.
    Min KS; Kobayashi K; Onosaka S; Ohta N; Okada Y; Tanaka K
    Toxicol Appl Pharmacol; 1986 Nov; 86(2):262-70. PubMed ID: 3787624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of N-benzyl-D-glucamine dithiocarbamate on renal toxicity induced by cadmium-metallothionein in rats.
    Kojima S; Ono H; Furukawa A; Kiyozumi M
    Arch Toxicol; 1990; 64(2):91-6. PubMed ID: 2350240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
    Min KS; Onosaka S; Tanaka K
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of renal metallothionein against Cd nephropathy in rats.
    Min KS; Hatta A; Onosaka S; Ohta N; Okada Y; Tanaka K
    Toxicol Appl Pharmacol; 1987 Apr; 88(2):294-301. PubMed ID: 3564045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadmium accumulation and metallothionein concentrations after 4-week dietary exposure to cadmium chloride or cadmium-metallothionein in rats.
    Groten JP; Sinkeldam EJ; Luten JB; van Bladeren PJ
    Toxicol Appl Pharmacol; 1991 Dec; 111(3):504-13. PubMed ID: 1746026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium-metallothionein in nephrotoxicity.
    Dudley RE; Gammal LM; Klaassen CD
    Toxicol Appl Pharmacol; 1985 Mar; 77(3):414-26. PubMed ID: 3975909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mucosal metallothionein in small intestine on tissue distribution of cadmium after oral administration of cadmium compounds.
    Min KS; Nakatsubo T; Kawamura S; Fujita Y; Onosaka S; Tanaka K
    Toxicol Appl Pharmacol; 1992 Apr; 113(2):306-10. PubMed ID: 1561640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
    Vestergaard P; Shaikh ZA
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cadmium-metallothionein pretreatment on tolerance of rat kidney cortical cells to cadmium toxicity in vitro and in vivo.
    Jin T; Nordberg GF; Nordberg M
    Pharmacol Toxicol; 1987 May; 60(5):345-9. PubMed ID: 3615344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure.
    Liu Y; Liu J; Habeebu SS; Klaassen CD
    Toxicol Sci; 1999 Aug; 50(2):221-7. PubMed ID: 10478858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
    Dorian C; Gattone VH; Klaassen CD
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous metallothionein and renal toxicity of cadmium and mercury in rats.
    Chan HM; Satoh M; Zalups RK; Cherian MG
    Toxicology; 1992 Nov; 76(1):15-26. PubMed ID: 1475792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney synthesizes less metallothionein than liver in response to cadmium chloride and cadmium-metallothionein.
    Sendelbach LE; Klaassen CD
    Toxicol Appl Pharmacol; 1988 Jan; 92(1):95-102. PubMed ID: 3341030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex.
    Liu J; Liu Y; Habeebu SS; Klaassen CD
    Toxicol Sci; 1998 Nov; 46(1):197-203. PubMed ID: 9928683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative renal toxicity of metallothioneins with different cadmium/zinc ratios in rats.
    Kojima S; Furukawa A; Kiyozumi M; Shimada H
    Toxicol Lett; 1991 Apr; 56(1-2):197-205. PubMed ID: 2017779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
    Liu J; Habeebu SS; Liu Y; Klaassen CD
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal discrimination between strontium and calcium in rats. Effects of renal damage caused by cadmium-metallothionein.
    Sugihira N; Suzuki KT
    Biol Trace Elem Res; 1989 Oct; 22(1):71-82. PubMed ID: 2484230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of cadmium chloride and cadmium-metallothionein to liver parenchymal, Kupffer, and endothelial cells: their relative ability to express metallothionein.
    McKim JM; Liu J; Liu YP; Klaassen CD
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):324-30. PubMed ID: 1539169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of intravenously injected cadmium-metallothionein: critical concentration and tolerance.
    Maitani T; Cuppage FE; Klaassen CD
    Fundam Appl Toxicol; 1988 Jan; 10(1):98-108. PubMed ID: 3350234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice.
    Liu J; Liu Y; Habeebu SM; Waalkes MP; Klaassen CD
    Toxicology; 2000 Jul; 147(3):157-66. PubMed ID: 10924798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.